Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
October 7, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for January 8, 2006 Subscribe to this News Feed      
 

Billie Jean King and Novo Nordisk Offer Scholarships to Young Tennis Players with Diabetes

Billie Jean King WTT Charities and Novo Nordisk are offering two scholarships of $5,000 each. Candidates must be between ages 14-21, play tennis competitively, and have diabetes. Deadline for application is May 1, 2006. For more information log on to www.wtt.com/charities.

(PRWEB) January 8, 2006 -- Novo Nordisk, the leading pharmaceutical company in diabetes care, is teaming up with Billie Jean King WTT Charities to present the Novo Nordisk Donnelly Awards. Billie Jean King established the awards in 1998 to encourage diabetic children to lead an active life and compete in tennis. The two awards each provide $5,000 scholarships to young tennis players suffering from diabetes. The award is named after two long-time World Team Tennis executives and tennis champions, Diane Donnelly Stone and Tracy Donnelly Maltby, who are sisters. Stone was an All-American and NCAA doubles champion at Northwestern University, and Maltby earned All-Big Ten honors at the University of Iowa. Both women have had diabetes since childhood.

Two young people, ages 14-21, who have diabetes and play tennis competitively in tournaments or on their school team will receive the $5,000 scholarships. In addition, the recipients will travel to a World Team Tennis match to receive their awards from Billie Jean King. All applications must be received by May 1, 2006, and the winners will be announced by June 15, 2006. For more information and to download an application log on to www.wtt.com and click on BJK/WTT Charities.

Novo Nordisk is a health care company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women.

For further information contact:

Diane Stone
Billie Jean King WTT Charities, Inc


###

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Anne Guerrant
Billie Jean King WTT CHARITIES
602-740-5622
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright